MAPK8 and colorectal carcinoma: We thus turned into the alternative pathways and found that rGal-8 elicited temporal activation of JNK and ERK in CRC cells, which can not be affected by LY2109761 treatment (Fig. 5F and Supplementary Fig. S5C).